Evidence map›Paper›PMID 30022561›Full record

ArticlePharmacoepidemiology and drug safety2018

Comparison of privacy-protecting analytic and data-sharing methods: A simulation study.

Kazuki Yoshida, Susan Gruber, Bruce H Fireman, Sengwee Toh

Abstract readComparative Study
In one paragraph

Article in Pharmacoepidemiology and drug safety, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care.Journal of the American Society of Nephrology : JASN · 2020
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Data Integration in Causal Inference.Wiley interdisciplinary reviews. Computational statistics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kazuki YoshidaDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0002-2030-3549
Susan GruberDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.ORCID 0000-0003-0127-0099
Bruce H FiremanDivision of Research, Kaiser Permanente Northern California, Oakland, CA, USA.ORCID 0000-0003-1652-985X
Sengwee TohDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.ORCID 0000-0002-5160-0810

Funding

Privacy-protecting distributed analysis of biomedical big dataU01EB023683 · NIBIB · HARVARD PILGRIM HEALTH CARE, INC. · PI TOH, DARREN · 2016 to 2018
$1.4M
NIBIB NIH HHS U01 EB023683NIBIB NIH HHS U01EB023683Patient-Centered Outcomes Research Institute ME-1403-11305
6 · The paper itself

Abstract

purposePrivacy-protecting analytic and data-sharing methods that minimize the disclosure risk of sensitive information are increasingly important due to the growing interest in utilizing data across multiple sources. We conducted a simulation study to examine how avoiding sharing individual-level data in a distributed data network can affect analytic results.

methodsThe base scenario had four sites of varying sizes with 5% outcome incidence, 50% treatment prevalence, and seven confounders. We varied treatment prevalence, outcome incidence, treatment effect, site size, number of sites, and covariate distribution. Confounding adjustment was conducted using propensity score or disease risk score. We compared analyses of three types of aggregate-level data requested from sites: risk-set, summary-table, or effect-estimate data (meta-analysis) with benchmark results of analysis of pooled individual-level data. We assessed bias and precision of hazard ratio estimates as well as the accuracy of standard error estimates.

resultsAll the aggregate-level data-sharing approaches, regardless of confounding adjustment methods, successfully approximated pooled individual-level data analysis in most simulation scenarios. Meta-analysis showed minor bias when using inverse probability of treatment weights (IPTW) in infrequent exposure (5%), rare outcome (0.01%), and small site (5,000 patients) settings. SE estimates became less accurate for IPTW risk-set approach with less frequent exposure and for propensity score-matching meta-analysis approach with rare outcomes.

conclusionsOverall, we found that we can avoid sharing individual-level data and obtain valid results in many settings, although care must be taken with meta-analysis approach in infrequent exposure and rare outcome scenarios, particularly when confounding adjustment is performed with IPTW.

Indexed as

Computer SecurityConfidentialityData AnalysisBiasComputer SimulationHumansInformation Disseminationdistributed databasespharmacoepidemiologyprivacy-protecting methodspropensity score

Identifiers

PMID30022561
PMCPMC6135666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.